It looks like you're using an Ad Blocker.

Please white-list or disable AboveTopSecret.com in your ad-blocking tool.

Thank you.

 

Some features of ATS will be disabled while you continue to use an ad-blocker.

 

FDA approves trial of stem cells for autistic disorder

page: 1
1

log in

join
share:

posted on Aug, 27 2012 @ 12:59 PM
link   
Michael Chez, M.D. is medical director of Pediatric Neurology at Sutter Neuroscience Institute, Sacramento, California.

After noticing improvement in the symptoms of neurologic conditions following umbilical stem cells, he applied for a trial of umbilical stem cells in autistic disorder.

The FDA have approved this trial.

Detailed Description:

"This is a single-center, randomized, placebo-controlled, crossover outpatient study with 15 subjects receiving one infusion of autologous umbilical cord blood (AUCB) containing a minimum of 10 million total nucleated cells per kilogram (TNC/kg) and 15 subjects receiving an infusion of placebo (saline). After the 24-week follow-up testing is conducted, the groups will crossover so that patients who initially received AUCB will receive placebo and patients who received placebo at baseline will receive the cord blood. Both groups will be tested again 24-weeks after infusion. The neuropsychologist, PI, staff from Cord Blood Registry (CBR), and parents will be blinded as to the infusion sequence.

The duration of participation for each study subject is approximately 55 weeks. This includes one screening visit over a period of approximately 6 weeks, one visit for baseline testing, one day for infusion of TNC (minimum 10 million/kg) or saline placebo followed by 24 weeks of follow-up. A second baseline visit is conducted at week-24 with the second infusion of TNC or saline placebo occurring 5-7 days after. Twenty-four additional weeks of follow-up occur after the second infusion."

Inclusion and exclusion criteria are here:
clinicaltrials.gov...

Could be interesting.



posted on Aug, 27 2012 @ 01:05 PM
link   
I worry that we don't know enough about Aspbergers (Autism) Disorder to apply this kind of "treatment" effectively yet. Research may show improvements in simulations but it is clear that autism is not a "black and white" kind of problem. It affects many different children, at different ages, to varying degrees. The world is not ready for this yet.

So, rather than trying to FIX the problem with the child, let us focus on fixing the problem in society and with the adults who are around these children. Early intervention and proper teaching tools are extremely effective in most cases of autistic children. This seems like a better approach than a scientific "cure" at this point.



 
1

log in

join